Your session is about to expire
← Back to Search
Behavioural Intervention
Wearable Device for Stroke Rehabilitation
N/A
Recruiting
Led By Victor H Duenas, PhD
Research Sponsored by Victor H. Duenas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
For able-bodied individuals, adults with no known neurological conditions or history of orthopedic injuries
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to end of intervention at approximately 1 week
Awards & highlights
Study Summary
This trial is designed to study whether a new wearable device and algorithm can help improve the function of the soleus muscle after a stroke.
Who is the study for?
This trial is for adults who can walk at least 10 meters with or without help. Healthy participants should have no neurological issues or past major injuries. Stroke survivors must be stable for over 6 months, able to use a robotic ankle device, and not expecting medication changes for 4 months.Check my eligibility
What is being tested?
The study tests how the soleus muscle in the calf responds during walking after stroke. It uses a powered ankle device and control algorithm on a treadmill to see if it can improve muscle response and gait speed by conditioning the muscles during stance phase.See study design
What are the potential side effects?
There are no specific side effects mentioned, but participants may experience discomfort from wearing the robotic device or fatigue from treadmill walking exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have no neurological conditions or past orthopedic injuries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from enrollment to end of intervention at approximately 1 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to end of intervention at approximately 1 week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in soleus EMG response
Trial Design
1Treatment groups
Experimental Treatment
Group I: Soleus Loading Response ExperimentalExperimental Treatment2 Interventions
Participants in this one arm will be administered the soleus loading response protocol by applying an ankle joint rotation during treadmill walking
Find a Location
Who is running the clinical trial?
Victor H. DuenasLead Sponsor
Medical University of South CarolinaOTHER
933 Previous Clinical Trials
7,394,595 Total Patients Enrolled
67 Trials studying Stroke
60,031 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,964 Previous Clinical Trials
2,674,710 Total Patients Enrolled
79 Trials studying Stroke
5,367 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there a cap on the number of participants for this investigation?
"Affirmative, the information available on clinicaltrials.gov indicates that this research is still recruiting participants. The medical study was first published on September 30th 2022 and saw its last update dated November 7th 2022. Currently, it needs to recruit 20 subjects from a single site."
Answered by AI
Is enrollment open for participants in this trial?
"Affirmative. Clinicaltrials.gov information indicates that this clinical trial, first posted on September 30th 2022, is actively seeking participants. Currently, 20 patients are being enrolled from one centre."
Answered by AI
Who else is applying?
What site did they apply to?
Syracuse University
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger